Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02584309
Title Doxorubicin With Upfront Dexrazoxane Plus Olaratumab for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

angiosarcoma

malignant peripheral nerve sheath tumor

malignant fibrous histiocytoma

leiomyosarcoma

epithelioid sarcoma

sarcoma

fibrosarcoma

synovial sarcoma

Therapies

Dexrazoxane

Doxorubicin + Olaratumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.